Login / Signup

Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma.

Rajshekhar ChakrabortyHeloise CheruvalathAnannya PatwariAniko SzaboCarolina D SchinkeBinod DhakalSuzanne LentzschAnita D'SouzaGhulam Rehman MohyuddinKelley JulianShonali MidhaPatrick CostelloMartin F KaiserMelissa Ng Liet HingSimon James HarrisonEdward Robert Scheffer CliffMeera Mohan
Published in: Blood cancer journal (2024)
Keyphrases
  • multiple myeloma
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • hodgkin lymphoma
  • disease activity
  • newly diagnosed
  • ulcerative colitis
  • stem cells
  • rheumatoid arthritis
  • mesenchymal stem cells